Abstract

Introduction

delirium following surgery is common and is associated with negative outcomes. Preoperative cognitive impairment has been shown to be a risk factor for post-operative delirium. Often the cognitive tests used are cumbersome. This study tests the hypothesis that the quantification of brain vulnerability, using Apolipoprotein E (ApoE) status and neuropsychological tests, both traditional and more easily administered, can quantify the risk of post-operative delirium following elective primary arthroplasty surgery.

Methods

this observational cohort study recruited participants aged 65 years or older admitted prior to elective primary hip or knee arthroplasty. Baseline data was collected and participants underwent neuropsychological testing and had blood taken for ApoE genotyping preoperatively. Post-operatively participants were assessed daily for delirium using the Confusion Assessment Method (CAM) and charts were reviewed where possible for reports of delirium. Univariate and multivariate analyses of preoperative factors were undertaken to identify independent predictors of delirium.

Results

between March 2012 and October 2014, 315 participants completed the study with an overall incidence of post-operative delirium of 40/315 (12.7%). Of these 18 fulfilled the CAM criteria for delirium and 22 were deemed delirious by consensus decision based on chart review. ApoE genotype was not associated with post-operative delirium in this cohort. Time taken to complete Colour Trails 2, errors in mini mental state examination and level of pain preoperatively were independent predictors of post-operative delirium.

Conclusions

this study challenges the assertion that ApoE4 genotype predicts post-operative delirium. It replicates previous work suggesting cognitive impairment predicts post-operative delirium and shows for the 1st time that simple cognitive tests can be as effective as more detailed tests.

Introduction

Post-operative delirium is a serious event for patients, families and healthcare workers and is associated with negative outcomes including cognitive impairment, institutionalisation and death [1]. Central to delirium pathophysiology, and ultimately prevention and treatment lies in the interaction of patient vulnerability and precipitating insult(s). Cardiac and hip fracture surgery involving, as they do, significant iatrogenic insults and frail populations, respectively, have accounted for the majority of post-operative delirium research to date [1]. Elective and emergency (most commonly to treat hip fracture) orthopaedic surgeries are often considered as a single entity but they are very different populations with elective patients being younger and more robust [2, 3]. Elective orthopaedic surgical procedures can also in themselves vary significantly, a revision hip arthroplasty will often take longer, cause more blood loss and require more analgesia than a primary arthroplasty for example.

Identification of predictors of post-operative delirium will facilitate preoperative informed consent; evidence has shown that multidisciplinary modification of perioperative care can reduce delirium incidence [4]. It is not yet clear which modifications of anaesthetic techniques or drug regimens reduce delirium risk and better risk stratification will improve future observational and interventional studies.

Systematic reviews of predictors of post-operative delirium across surgical populations have consistently identified cognitive impairment as a main predictive factor of post-operative delirium [5, 6]. Several studies have investigated the utility of detailed cognitive tests in the prediction of post-operative delirium in non-cardiac surgical populations, however, conclusions have varied [711]. Participants in these studies underwent a variety of surgical procedures so there is lack of homeogeneity. Also detailed cognitive tests require staff training, are time-consuming and so are resource-heavy. After increasing age, carriage of an Apolipoprotein E ε4 (ApoE4) allele is the next most influential risk factor for Alzheimer's disease (AD), the most common cause of dementia. Whilst it is neither necessary for nor indicative of developing AD dementia, the ApoE4 allele has been associated with amyloid accumulation in those without cognitive impairment. Studies have considered ApoE4 as a risk factor for delirium in ICU, medical, hip fracture and elective populations [1215] with a meta-analysis in 2009 suggesting an association between ApoE4 carriage and delirium [12].

This observational cohort study tested the hypotheses that:

  1. Carriage of an ApoE4 allele is associated with an increased risk of post-operative delirium.

  2. Impaired preoperative neuropsychological performance is associated with a higher incidence of post-operative delirium.

  3. More easily administered neuropsychological tests are as effective as more detailed assessments.

Methods

Study population

Participants aged 65 years or older admitted for primary elective hip or knee arthroplasty to a single surgical centre under the care of three participating consultant orthopaedic surgeons who were expected to undergo spinal anaesthesia with intrathecal diamorphine were eligible for inclusion. Other anaesthetic variations were permitted.

Exclusion criteria: a pre-existing diagnosis of dementia or other neurodegenerative condition; visual or hearing impairment such that the participant was unable to undertake the neuropsychological assessments; illiteracy; colour blindness; stroke with residual deficit.

Study methods

Written informed consent was obtained from all participants and the study was performed in accordance with local ethical committee procedures (REC reference: 10/NIR01/5; protocol number: 09069 PP-OPMS). Available medical notes were reviewed and demographic and baseline data, including a comorbidity index [16], American Society of Anesthesiologists (ASA) physical status [17], number of medications, smoking status and alcohol consumption, recorded as outlined in Table 1.

Table 1.

Characteristics, including baseline performance in neuropsychological assessments, for delirium and no delirium groups

VariableTotal cohort (n = 315)Delirium (n = 40)No delirium (n = 275)Test statisticP value
Age in years, mean (SD)
  • 74.4 (5.8)

  • Range 65–92

76.9 (6.0)74.0 (5.7)T = −2.945<0.01
Male (%)136 (43.2)18/40 (45)118/275 (42.9)Χ2 = 0.0060.94
Hip arthroplasty (%)
remainder underwent knee arthroplasty
159 (50.5)14/40 (35)145/275 (52.7)Χ2 = 3.7090.05
ASA physical status (I/II/III)
  • 15/250/46

  • n = 311

1/30/914/220/37MWU = 4,840.50.11
Charlson Comorbidity Index (1), 0/1/2/3/4
  • 177/96/26/6/1

  • n = 306

17/13/7/1/0160/83/19/5/1MWU = 4,172.50.04
Number of medications, mean (SD)
  • 5.8 (3.5)

  • Range 0–18

  • n = 275

6.3 (4.2)5.8 (3.4)T = −0.9260.36
Years in education, mean (SD)
  • 11.7 (2.2)

  • Range 6–17

  • n = 312

11.4 (2.1)11.8 (2.3)T = 1.0490.30
Smoking status, current smokers (%)
  • 22 (7.1)

  • n = 312

4/39 (10.3)18/273 (6.6)FET0.50
Units alcohol, ≥11 units/week (%)
  • 32 (10.3)

  • n = 312

3/40 (7.5)29/272 (10.7)FET0.78
Bristol activities of daily living score (2), median (IQR)
  • 2 (1–3)

  • Range 0–16

  • n = 314

3 (1–3)2 (1–3)MWU = 5,310.50.75
Geriatric Depression Scale score (3), mean (SD)
  • 5.9 (1.7)

  • Range 0–11

  • n = 229

5.9 (1.9)5.9 (1.6)T = −0.0600.95
VVAS at rest component, median (IQR)
  • 26 (7–55)

  • Range 0–96

  • n = 313

14 (3–29)28 (8–56.25)MWU = 3,885<0.01
VVAS on movement component, median (IQR)
  • 75 (55–88.5)

  • Range 7–100

  • n = 313

72 (52–85)76 (55.75–89)MWU = 4,914.50.42
Estimated IQ from National Adult Reading Test errors, mean (SD)
  • 109.5 (9.5)

  • n = 311

  • Range 87.3–128.0

106.8 (9.1)109.9 (9.5)T = 1.9570.05
≥1ApoE4 allele (%)
  • 78 (25.1)

  • n = 311

12 (30.1)66 (24.3)Χ2 = 0.7680.38
CLOX 1, median (IQR)
  • 13 (11–14)

  • n = 303

12 (11.25–13)13 (11–14)MWU = 4,553.50.16
CLOX 2, median (IQR)
  • 14 (13–15)

  • n = 303

14 (13–14.75)14 (13–15)MWU = 5,1970.90
Mean letter fluency, mean (SD)
  • 11.8 (4.7)

  • Range 0.7–27.0

  • n = 315

10.7 (4.4)11.9 (4.7)T = 1.6200.11
Mean category fluency, mean (SD)
  • 17.0 (4.3)

  • Range 6.5–30.0

  • n = 315

15.0 (4.2)17.3 (4.3)T = 3.099<0.01
Stroop Colour Word Score, mean (SD)
  • 23.7 (9.0)

  • Range 4–52

  • n = 309

20.0 (7.9)24.3 (9.0)T = 2.789<0.01
Log-transformed Colour Trails 1 time, geometric mean (IQR)
  • (50–88)

  • n = 313

82.3 (54–110)66.6 (49–84.5)
  • Ratio of means (95% CI)

  • 1.24 (1.02–1.50)

0.03
Log-transformed Colour Trails 2 time, geometric mean (IQR)
  • (108––188)

  • n = 307

178.5 (129–246)140.2 (107–185)
  • Ratio of means (95% CI)

  • 1.27 (1.11–1.46)

<0.01
New York Paragraph Recall Test immediate recall, mean (SD)
  • 4.6 (2.1)

  • Range 0–12

  • n = 315

4.2 (1.8)4.6 (2.2)T = 1.2960.20
New York Paragraph Recall Test delayed recall, mean (SD)
  • 5.1 (2.9)

  • Range 0–14

  • n = 314

4.1 (2.7)5.3 (2.9)T = 2.4820.01
MMSE score, mean (SD)
  • 27.3 (2.3)

  • Range 16–30

  • n = 290

26.2 (2.7)27.4 (2.2)T = 3.129<0.01
MOTYB score, median (IQR)
  • 12 (12)

  • Range 1–12

  • n = 149

12 (12)12 (12)MWU = 1,503.50.70
MOTYB any error (%)
  • 21 (14.1)

  • n = 149

3/25 (12)18/124 (14.5)FET1.00
VariableTotal cohort (n = 315)Delirium (n = 40)No delirium (n = 275)Test statisticP value
Age in years, mean (SD)
  • 74.4 (5.8)

  • Range 65–92

76.9 (6.0)74.0 (5.7)T = −2.945<0.01
Male (%)136 (43.2)18/40 (45)118/275 (42.9)Χ2 = 0.0060.94
Hip arthroplasty (%)
remainder underwent knee arthroplasty
159 (50.5)14/40 (35)145/275 (52.7)Χ2 = 3.7090.05
ASA physical status (I/II/III)
  • 15/250/46

  • n = 311

1/30/914/220/37MWU = 4,840.50.11
Charlson Comorbidity Index (1), 0/1/2/3/4
  • 177/96/26/6/1

  • n = 306

17/13/7/1/0160/83/19/5/1MWU = 4,172.50.04
Number of medications, mean (SD)
  • 5.8 (3.5)

  • Range 0–18

  • n = 275

6.3 (4.2)5.8 (3.4)T = −0.9260.36
Years in education, mean (SD)
  • 11.7 (2.2)

  • Range 6–17

  • n = 312

11.4 (2.1)11.8 (2.3)T = 1.0490.30
Smoking status, current smokers (%)
  • 22 (7.1)

  • n = 312

4/39 (10.3)18/273 (6.6)FET0.50
Units alcohol, ≥11 units/week (%)
  • 32 (10.3)

  • n = 312

3/40 (7.5)29/272 (10.7)FET0.78
Bristol activities of daily living score (2), median (IQR)
  • 2 (1–3)

  • Range 0–16

  • n = 314

3 (1–3)2 (1–3)MWU = 5,310.50.75
Geriatric Depression Scale score (3), mean (SD)
  • 5.9 (1.7)

  • Range 0–11

  • n = 229

5.9 (1.9)5.9 (1.6)T = −0.0600.95
VVAS at rest component, median (IQR)
  • 26 (7–55)

  • Range 0–96

  • n = 313

14 (3–29)28 (8–56.25)MWU = 3,885<0.01
VVAS on movement component, median (IQR)
  • 75 (55–88.5)

  • Range 7–100

  • n = 313

72 (52–85)76 (55.75–89)MWU = 4,914.50.42
Estimated IQ from National Adult Reading Test errors, mean (SD)
  • 109.5 (9.5)

  • n = 311

  • Range 87.3–128.0

106.8 (9.1)109.9 (9.5)T = 1.9570.05
≥1ApoE4 allele (%)
  • 78 (25.1)

  • n = 311

12 (30.1)66 (24.3)Χ2 = 0.7680.38
CLOX 1, median (IQR)
  • 13 (11–14)

  • n = 303

12 (11.25–13)13 (11–14)MWU = 4,553.50.16
CLOX 2, median (IQR)
  • 14 (13–15)

  • n = 303

14 (13–14.75)14 (13–15)MWU = 5,1970.90
Mean letter fluency, mean (SD)
  • 11.8 (4.7)

  • Range 0.7–27.0

  • n = 315

10.7 (4.4)11.9 (4.7)T = 1.6200.11
Mean category fluency, mean (SD)
  • 17.0 (4.3)

  • Range 6.5–30.0

  • n = 315

15.0 (4.2)17.3 (4.3)T = 3.099<0.01
Stroop Colour Word Score, mean (SD)
  • 23.7 (9.0)

  • Range 4–52

  • n = 309

20.0 (7.9)24.3 (9.0)T = 2.789<0.01
Log-transformed Colour Trails 1 time, geometric mean (IQR)
  • (50–88)

  • n = 313

82.3 (54–110)66.6 (49–84.5)
  • Ratio of means (95% CI)

  • 1.24 (1.02–1.50)

0.03
Log-transformed Colour Trails 2 time, geometric mean (IQR)
  • (108––188)

  • n = 307

178.5 (129–246)140.2 (107–185)
  • Ratio of means (95% CI)

  • 1.27 (1.11–1.46)

<0.01
New York Paragraph Recall Test immediate recall, mean (SD)
  • 4.6 (2.1)

  • Range 0–12

  • n = 315

4.2 (1.8)4.6 (2.2)T = 1.2960.20
New York Paragraph Recall Test delayed recall, mean (SD)
  • 5.1 (2.9)

  • Range 0–14

  • n = 314

4.1 (2.7)5.3 (2.9)T = 2.4820.01
MMSE score, mean (SD)
  • 27.3 (2.3)

  • Range 16–30

  • n = 290

26.2 (2.7)27.4 (2.2)T = 3.129<0.01
MOTYB score, median (IQR)
  • 12 (12)

  • Range 1–12

  • n = 149

12 (12)12 (12)MWU = 1,503.50.70
MOTYB any error (%)
  • 21 (14.1)

  • n = 149

3/25 (12)18/124 (14.5)FET1.00

MWU, Mann–Whitney U-test; FET, Fisher's Exact test; IQR, interquartile range; CI, confidence intervals.

Absolute number of medications was calculated as a crude measure of drug burden with each medication, including as required medications, inhalers and eye drops, assigned a value of one. Level of education was recorded as years of education, assuming age at starting school of 4 years. Alcohol units per week were estimated using the calculator at www.drinkaware.co.uk. Smoking status was recorded as current, ex or non-smoking.

P values significant at the 5% level are shown in bold.

Table 1.

Characteristics, including baseline performance in neuropsychological assessments, for delirium and no delirium groups

VariableTotal cohort (n = 315)Delirium (n = 40)No delirium (n = 275)Test statisticP value
Age in years, mean (SD)
  • 74.4 (5.8)

  • Range 65–92

76.9 (6.0)74.0 (5.7)T = −2.945<0.01
Male (%)136 (43.2)18/40 (45)118/275 (42.9)Χ2 = 0.0060.94
Hip arthroplasty (%)
remainder underwent knee arthroplasty
159 (50.5)14/40 (35)145/275 (52.7)Χ2 = 3.7090.05
ASA physical status (I/II/III)
  • 15/250/46

  • n = 311

1/30/914/220/37MWU = 4,840.50.11
Charlson Comorbidity Index (1), 0/1/2/3/4
  • 177/96/26/6/1

  • n = 306

17/13/7/1/0160/83/19/5/1MWU = 4,172.50.04
Number of medications, mean (SD)
  • 5.8 (3.5)

  • Range 0–18

  • n = 275

6.3 (4.2)5.8 (3.4)T = −0.9260.36
Years in education, mean (SD)
  • 11.7 (2.2)

  • Range 6–17

  • n = 312

11.4 (2.1)11.8 (2.3)T = 1.0490.30
Smoking status, current smokers (%)
  • 22 (7.1)

  • n = 312

4/39 (10.3)18/273 (6.6)FET0.50
Units alcohol, ≥11 units/week (%)
  • 32 (10.3)

  • n = 312

3/40 (7.5)29/272 (10.7)FET0.78
Bristol activities of daily living score (2), median (IQR)
  • 2 (1–3)

  • Range 0–16

  • n = 314

3 (1–3)2 (1–3)MWU = 5,310.50.75
Geriatric Depression Scale score (3), mean (SD)
  • 5.9 (1.7)

  • Range 0–11

  • n = 229

5.9 (1.9)5.9 (1.6)T = −0.0600.95
VVAS at rest component, median (IQR)
  • 26 (7–55)

  • Range 0–96

  • n = 313

14 (3–29)28 (8–56.25)MWU = 3,885<0.01
VVAS on movement component, median (IQR)
  • 75 (55–88.5)

  • Range 7–100

  • n = 313

72 (52–85)76 (55.75–89)MWU = 4,914.50.42
Estimated IQ from National Adult Reading Test errors, mean (SD)
  • 109.5 (9.5)

  • n = 311

  • Range 87.3–128.0

106.8 (9.1)109.9 (9.5)T = 1.9570.05
≥1ApoE4 allele (%)
  • 78 (25.1)

  • n = 311

12 (30.1)66 (24.3)Χ2 = 0.7680.38
CLOX 1, median (IQR)
  • 13 (11–14)

  • n = 303

12 (11.25–13)13 (11–14)MWU = 4,553.50.16
CLOX 2, median (IQR)
  • 14 (13–15)

  • n = 303

14 (13–14.75)14 (13–15)MWU = 5,1970.90
Mean letter fluency, mean (SD)
  • 11.8 (4.7)

  • Range 0.7–27.0

  • n = 315

10.7 (4.4)11.9 (4.7)T = 1.6200.11
Mean category fluency, mean (SD)
  • 17.0 (4.3)

  • Range 6.5–30.0

  • n = 315

15.0 (4.2)17.3 (4.3)T = 3.099<0.01
Stroop Colour Word Score, mean (SD)
  • 23.7 (9.0)

  • Range 4–52

  • n = 309

20.0 (7.9)24.3 (9.0)T = 2.789<0.01
Log-transformed Colour Trails 1 time, geometric mean (IQR)
  • (50–88)

  • n = 313

82.3 (54–110)66.6 (49–84.5)
  • Ratio of means (95% CI)

  • 1.24 (1.02–1.50)

0.03
Log-transformed Colour Trails 2 time, geometric mean (IQR)
  • (108––188)

  • n = 307

178.5 (129–246)140.2 (107–185)
  • Ratio of means (95% CI)

  • 1.27 (1.11–1.46)

<0.01
New York Paragraph Recall Test immediate recall, mean (SD)
  • 4.6 (2.1)

  • Range 0–12

  • n = 315

4.2 (1.8)4.6 (2.2)T = 1.2960.20
New York Paragraph Recall Test delayed recall, mean (SD)
  • 5.1 (2.9)

  • Range 0–14

  • n = 314

4.1 (2.7)5.3 (2.9)T = 2.4820.01
MMSE score, mean (SD)
  • 27.3 (2.3)

  • Range 16–30

  • n = 290

26.2 (2.7)27.4 (2.2)T = 3.129<0.01
MOTYB score, median (IQR)
  • 12 (12)

  • Range 1–12

  • n = 149

12 (12)12 (12)MWU = 1,503.50.70
MOTYB any error (%)
  • 21 (14.1)

  • n = 149

3/25 (12)18/124 (14.5)FET1.00
VariableTotal cohort (n = 315)Delirium (n = 40)No delirium (n = 275)Test statisticP value
Age in years, mean (SD)
  • 74.4 (5.8)

  • Range 65–92

76.9 (6.0)74.0 (5.7)T = −2.945<0.01
Male (%)136 (43.2)18/40 (45)118/275 (42.9)Χ2 = 0.0060.94
Hip arthroplasty (%)
remainder underwent knee arthroplasty
159 (50.5)14/40 (35)145/275 (52.7)Χ2 = 3.7090.05
ASA physical status (I/II/III)
  • 15/250/46

  • n = 311

1/30/914/220/37MWU = 4,840.50.11
Charlson Comorbidity Index (1), 0/1/2/3/4
  • 177/96/26/6/1

  • n = 306

17/13/7/1/0160/83/19/5/1MWU = 4,172.50.04
Number of medications, mean (SD)
  • 5.8 (3.5)

  • Range 0–18

  • n = 275

6.3 (4.2)5.8 (3.4)T = −0.9260.36
Years in education, mean (SD)
  • 11.7 (2.2)

  • Range 6–17

  • n = 312

11.4 (2.1)11.8 (2.3)T = 1.0490.30
Smoking status, current smokers (%)
  • 22 (7.1)

  • n = 312

4/39 (10.3)18/273 (6.6)FET0.50
Units alcohol, ≥11 units/week (%)
  • 32 (10.3)

  • n = 312

3/40 (7.5)29/272 (10.7)FET0.78
Bristol activities of daily living score (2), median (IQR)
  • 2 (1–3)

  • Range 0–16

  • n = 314

3 (1–3)2 (1–3)MWU = 5,310.50.75
Geriatric Depression Scale score (3), mean (SD)
  • 5.9 (1.7)

  • Range 0–11

  • n = 229

5.9 (1.9)5.9 (1.6)T = −0.0600.95
VVAS at rest component, median (IQR)
  • 26 (7–55)

  • Range 0–96

  • n = 313

14 (3–29)28 (8–56.25)MWU = 3,885<0.01
VVAS on movement component, median (IQR)
  • 75 (55–88.5)

  • Range 7–100

  • n = 313

72 (52–85)76 (55.75–89)MWU = 4,914.50.42
Estimated IQ from National Adult Reading Test errors, mean (SD)
  • 109.5 (9.5)

  • n = 311

  • Range 87.3–128.0

106.8 (9.1)109.9 (9.5)T = 1.9570.05
≥1ApoE4 allele (%)
  • 78 (25.1)

  • n = 311

12 (30.1)66 (24.3)Χ2 = 0.7680.38
CLOX 1, median (IQR)
  • 13 (11–14)

  • n = 303

12 (11.25–13)13 (11–14)MWU = 4,553.50.16
CLOX 2, median (IQR)
  • 14 (13–15)

  • n = 303

14 (13–14.75)14 (13–15)MWU = 5,1970.90
Mean letter fluency, mean (SD)
  • 11.8 (4.7)

  • Range 0.7–27.0

  • n = 315

10.7 (4.4)11.9 (4.7)T = 1.6200.11
Mean category fluency, mean (SD)
  • 17.0 (4.3)

  • Range 6.5–30.0

  • n = 315

15.0 (4.2)17.3 (4.3)T = 3.099<0.01
Stroop Colour Word Score, mean (SD)
  • 23.7 (9.0)

  • Range 4–52

  • n = 309

20.0 (7.9)24.3 (9.0)T = 2.789<0.01
Log-transformed Colour Trails 1 time, geometric mean (IQR)
  • (50–88)

  • n = 313

82.3 (54–110)66.6 (49–84.5)
  • Ratio of means (95% CI)

  • 1.24 (1.02–1.50)

0.03
Log-transformed Colour Trails 2 time, geometric mean (IQR)
  • (108––188)

  • n = 307

178.5 (129–246)140.2 (107–185)
  • Ratio of means (95% CI)

  • 1.27 (1.11–1.46)

<0.01
New York Paragraph Recall Test immediate recall, mean (SD)
  • 4.6 (2.1)

  • Range 0–12

  • n = 315

4.2 (1.8)4.6 (2.2)T = 1.2960.20
New York Paragraph Recall Test delayed recall, mean (SD)
  • 5.1 (2.9)

  • Range 0–14

  • n = 314

4.1 (2.7)5.3 (2.9)T = 2.4820.01
MMSE score, mean (SD)
  • 27.3 (2.3)

  • Range 16–30

  • n = 290

26.2 (2.7)27.4 (2.2)T = 3.129<0.01
MOTYB score, median (IQR)
  • 12 (12)

  • Range 1–12

  • n = 149

12 (12)12 (12)MWU = 1,503.50.70
MOTYB any error (%)
  • 21 (14.1)

  • n = 149

3/25 (12)18/124 (14.5)FET1.00

MWU, Mann–Whitney U-test; FET, Fisher's Exact test; IQR, interquartile range; CI, confidence intervals.

Absolute number of medications was calculated as a crude measure of drug burden with each medication, including as required medications, inhalers and eye drops, assigned a value of one. Level of education was recorded as years of education, assuming age at starting school of 4 years. Alcohol units per week were estimated using the calculator at www.drinkaware.co.uk. Smoking status was recorded as current, ex or non-smoking.

P values significant at the 5% level are shown in bold.

Baseline neuropsychological tests were undertaken as outlined in Table 1. Estimated intelligence quotient (IQ), pain and depression were assessed as recognised potential confounding factors. Cognitive tests were chosen to capture the breadth of cognitive domains (memory; executive function; language and visuospatial abilities) whilst focussing on executive function and attention testing the hypothesis that these more subtle deficits may be an earlier marker of brain vulnerability [18, 19]. The constituent parts of the Mini Mental State Examination (MMSE) [20] were scored individually.

Post-operatively participants were assessed for delirium once daily by a single researcher (T.M. initially then E.C.) for the 1st 3 days. The MMSE and the Confusion Assessment Method (CAM) [21] were completed on each occasion. Nursing staff were asked about symptoms of delirium as part of each assessment. Error(s) in WORLD backwards and/or, latterly, months of the year backwards (MOTYB) were not requisite or necessarily sufficient to fulfil the inattention feature of the CAM. Where possible, medical and nursing notes for all participants were interrogated post-discharge by the researchers or a research assistant. In all cases, where there were reports of delirium but the CAM criteria had not been fulfilled cases were discussed between E.C. and P.P. and a consensus reached as to whether they reflected delirium, according to Diagnostic and Statistical Manual of Mental Disorders IV criteria [22].

To reinforce the assessments an additional test of attention—MOTYB—and the modified Richmond Agitation and Sedation Scale [23] to quantify level of consciousness were added during the study, at participants 177 and 198, respectively.

For researcher training and quality control methods Supplementary data are available in Age and Ageing online.

DNA collection and analysis

Venous blood was collected preoperatively, at the point of intravenous cannulation, into PAXgene Blood DNA tubes (Qiagen, catalogue number: 761125). Samples were transported on wet ice to the laboratory where they were processed according to the manufacturer's instructions and stored at −80°C.

DNA was analysed using the TaqMan Single Nucleotide Polymorphism Genotyping Assay (Life Technologies; catalogue number 4351379) as per the manufacturer's instructions. ApoE status was inferred from the genotype at each of the two alleles, rs7412 and rs429358 [24].

Statistical methods

The study was powered to detect a difference in the risk of delirium between the ApoE4 positive and ApoE4 negative groups. This was based on an estimated ApoE4 carrier rate of 25.5% [25] and a rate of delirium in the ApoE4 positive and ApoE4 negative groups of 28% and 11%, respectively, in an elective non-cardiac surgery population [26]. It was estimated that 316 participants would be required to enable detection of significant difference, at the 5% significance level, with 90% power.

Baseline characteristics, ApoE allele status and neuropsychological performances were compared between the delirium and no delirium groups using t-tests, Mann–Whitney U-tests and chi-squared test with Yates’ correction (or Fisher's exact test) as appropriate. Positively skewed variables were logarithmically (log) transformed to facilitate parametric testing (further description in Supplementary data are available in Age and Ageing online). In keeping with conventional practice, MMSE scores were analysed using means and standard deviations (SDs), despite the distribution being negatively skewed. Binary logistic regression, with delirium as the dependent variable, was then used to calculate the adjusted odds ratio (OR) for each baseline variable. The significance level was set to 10% (P < 0.10) for initial entry into the logistic regression model. Variables were then eliminated in a stepwise fashion until all retained variables were significant (P < 0.05). Analysis was performed using SPSS for Windows version 22 (IBM Inc., Armonk, NY, USA).

Methods and results are presented in accordance with STROBE guidance [27] where possible.

Results

Between 23rd March 2012 and 21st October 2014, 338 participants were recruited with 315 completing the study. The numbers involved at each stage of the recruitment process are shown in Figure 1. The three participating surgeons undertook 2,083 primary hip and knee replacements in patients aged 65 or over during the study period. Mean (SD) age, with range, for the study cohort and entire potentially eligible cohort was 74.4 (5.8), 65–92 years and 74.2 (6.1), 65–95 years, respectively.

Flow chart showing eligible, excluded and withdrawn participants at each stage.
Figure 1.

Flow chart showing eligible, excluded and withdrawn participants at each stage.

Missing data

Participants were assessed post-operatively on complete inpatient days. If participants were not assessed during a full inpatient day and had not refused this was considered missing data (numbers are shown in Supplementary data, Table S1, available in Age and Ageing online). Each participant was assessed post-operatively on at least 1 day. Of the 315 participants completing the study, 159 charts were reviewed post-discharge.

Incidence of delirium

The cumulative incidence of delirium in the 1st three post-operative days was 40/315 (12.7%) with 18 CAM positive for delirium and 22 deemed to be delirium by reports. Delirium incidence by day and those symptoms deemed to represent delirium by consensus decision are shown in Supplementary data, Tables S2–S4, available in Age and Ageing online.

Predictors of delirium

DNA was unavailable for four participants. Of the remaining 311 participants six were homozygous for the E4 allele, 72 heterozygous and 233 non-carriers. No significant association was found between ApoE4 allele carriage and delirium.

The baseline characteristics and performance on cognitive testing of the total cohort, delirium and non-delirium groups, along with the results of the stated univariate analyses are shown in Table 1. Where there is missing data the n = available data is shown in the total cohort column.

Preoperative MMSE scores were considered for each section of the test. The baseline performance in the MMSE sections for the total cohort, delirium and no delirium groups is shown in Supplementary data, Table S5, available in Age and Ageing online. Making more than one error in orientation questions, an error in 3-item recall or in repetition were significantly associated with post-operative delirium in this cohort.

The results from the logistic regression model consisting of all variables significant at the 10% level on univariate analyses are shown in Table 2. These show that for each millimetre  increase in Vertical Visual Analogue Pain Scale, pain at rest score, the OR of delirium decreased by a factor of 0.98, for every 10-fold increase in time taken to complete Colour Trails 2 the OR of delirium increased by a factor of 15.93, making any error in 3-item recall increased the OR of delirium by a factor of 3.16, and making more than one error in orientation questions in the MMSE increased the OR of delirium by a factor of 7.75.

Table 2.

Independent predictors of post-operative delirium corrected for those variables significant at the 10% level

VariableP valueOR
VVAS, pain at rest0.020.98
Log transformed Colour Trails 2<0.0115.93
Any error in 3-item recall0.043.16
More than one error in orientation questions0.047.75
VariableP valueOR
VVAS, pain at rest0.020.98
Log transformed Colour Trails 2<0.0115.93
Any error in 3-item recall0.043.16
More than one error in orientation questions0.047.75
Table 2.

Independent predictors of post-operative delirium corrected for those variables significant at the 10% level

VariableP valueOR
VVAS, pain at rest0.020.98
Log transformed Colour Trails 2<0.0115.93
Any error in 3-item recall0.043.16
More than one error in orientation questions0.047.75
VariableP valueOR
VVAS, pain at rest0.020.98
Log transformed Colour Trails 2<0.0115.93
Any error in 3-item recall0.043.16
More than one error in orientation questions0.047.75

The incidence of delirium, by CAM and by reports, over the time course of the study was calculated. There was a difference (P = 0.053) between delirium rates before (15/167) and after (25/148) the introduction of the additional test of attention. The logistical regression model was run again with study epoch included as a variable and no independent association was found.

Discussion

First, this observational cohort study tested the hypothesis that carriage of an ApoE4 allele would be associated with an increased risk of post-operative delirium. The failure to show an association between ApoE4 carriage and post-operative delirium, in conjunction with recent work [28, 29] challenges the conclusions of a 2009 meta-analysis [12] in the post-operative population.

Results from both univariate and multivariate analyses supported the secondary hypothesis, that is, that impaired preoperative neuropsychological performance is associated with a higher incidence of post-operative delirium following elective primary hip and knee arthroplasty. The independent association between performance on Colour Trails 2 and subsequent delirium suggests it may be an adequate measure of cognitive vulnerability to delirium and is in keeping with previous similar work undertaken in elective, non-cardiac surgery populations [9, 11]. Furthermore, it may be related to the association between executive dysfunction and vascular risk factors [19] which were common in this study population. Modified from the Trail Making Test by D'Elia et al. [30] Colour Trails is a test of executive function and measures the time in seconds taken by participants to sequentially join alternately coloured circles numbered 1–25 arranged in an apparently random order. The mean values in this study population (mean age 74.4 years) are similar to those for the 70–75 years old age groups in a large study of older Irish adults [31].

Third, the study tested the hypothesis that more easily administered neuropsychological tests could be as effective as more detailed time and expertise consuming assessments. This is the 1st study, to the authors’ knowledge, to consider 3-item recall and more than one error in orientation questions as predictors of post-operative delirium. Pending replication, the inclusion of these simple cognitive tests could aid preoperative risk stratification and counselling and perioperative care planning. The high incidence of errors in 3-item recall in both delirium and no delirium groups would suggest its utility lies in highlighting those at decreased risk, who make no error, rather than identifying those at high risk by making an error. Making more than one error in orientation questions may be a more sensitive test for identifying those patients at higher risk. Consideration of these as binary variables may have increased the power available to demonstrate a significant association. It was felt, however, that these were the most appropriate methods to analyse the data.

The independent association between decreased levels of pain at rest and increased risk of post-operative delirium is in contrast to the published literature [3234]. Pain scores at rest are most representative of overall pain burden; patients less sensitised to pain at rest may experience the greatest increase in pain over the acute perioperative period, pre-disposing them to delirium. Further research into this area is warranted.

This study had a number of notable strengths and limitations. Delirium was diagnosed on daily assessment by specifically trained researchers using a validated tool. The overall incidence of post-operative delirium found in this study is in keeping with the published literature [35] (further discussion in the Supplementary data are available in Age and Ageing online). Introduction of additional outcome measures during a study is not ideal but it was felt that the CAM alone lacked objectivity which is supported by the recent publication of the 3D-CAM with supporting objective tests [36]. Symptoms of delirium falling short of a CAM positive screening for delirium were common in this study. It is possible that some participants with delirium were not identified using the relatively subjective marking of the CAM items. Future work will consider these subsyndromal delirium features further.

The inclusion of delirium by reports will have mitigated this risk to a certain extent. A validated chart review tool was not used, however, and 156 of the 315 charts were not reviewed. These were spread across the study period but more charts were reviewed in the 2nd epoch and this may have contributed to the increase with incidence over time. Alternatively this increased incidence over time may have been a true finding. Most published studies do not provide the level of detail outlined herein so it is difficult to know if or how these results regarding study epoch differ from previous studies.

No collateral history was taken preoperatively and diagnosis of dementia was not attempted. It is likely that a few patients with undiagnosed dementia (at an early stage) were included in the study. This is arguably more reflective of the elective arthroplasty population where cognitive impairment often goes unrecognised [37]. Hearing and visual impairment, which are recognised risk factors for delirium were not adequately recorded in this study. Spinal anaesthetic with intrathecal diamorphine was chosen as a constant at the outset as it was a most commonly used anaesthetic technique. The permission of various other anaesthetic measures introduces the potential for intraoperative confounding factors not captured by these analyses. Future work will need to further consider these confounders.

In conclusion, this study replicates previous work suggesting preoperative cognitive impairment, especially in a test of sustained attention/executive function, predicts post-operative delirium in a specific elective orthopaedic population. It shows for the 1st time that simple cognitive tests can be just as effective as more detailed tests. Along with recently published work it challenges the assertion that carriage of an ApoE4 allele predicts delirium, at least in the post-operative setting.

Key points

  • The incidence of post-operative delirium following elective primary hip and knee arthroplasty was 12.7% in this observational cohort study of patients aged 65 years and over.

  • Preoperative cognitive impairment predicts post-operative delirium.

  • Despite its established association with Alzheimer's disease dementia the Apoliprotein E4 allele does not predict post-operative delirium.

Supplementary data

Supplementary data are available at Age and Ageing online.

Acknowledgements

We gratefully acknowledge the generous support of: the theatre and ward staff of Musgrave Park Hospital; Dr James Murray, for his help and support during the planning of this project; Mr John Conlon, Mrs Hazel Johnston and Mrs Eilish Armstrong, for their laboratory and cognitive research expertise; Ms Lauren Anderson, for her help with data management and laboratory support; Professor Chris Patterson, for his statistical expertise and patience; Professor Alasdair MacLullich and team, for their generous advice.

Conflicts of Interest

None declared.

Funding

This work was supported by philanthropic funding, specifically the Siew Keok Chin Scholarship, and charitable funding, from the Belfast Arthroplasty Research Trust, both administered via Queen's University Belfast. Neither played a role in the planning, execution or reporting of this study.

References

1

Inouye
SK
,
Westendorp
RG
,
Saczynski
JS
.
Delirium in elderly people
.
Lancet
2014
;
383
:
911
22
.

2

The NJR Editorial Board
. 11th Annual Report National Joint Registry for England, Wales and Northern Ireland. Hertfordshire: National Joint Registry,
2014
. Report No.: 11.

3

Royal College of Physicians
.
National Hip Fracture Database Annual Report 2014
.
London
:
RCP
,
2014
.

4

Martinez
F
,
Tobar
C
,
Hill
N
.
Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature
.
Age Ageing
2015
;
44
:
196
204
.

5

Dasgupta
M
,
Dumbrell
AC
.
Preoperative risk assessment for delirium after noncardiac surgery: a systematic review
.
J Am Geriatr Soc
2006
;
54
:
1578
89
.

6

van Meenen
LC
,
van Meenen
DM
,
de Rooij
SE
,
ter Riet
G
.
Risk prediction models for postoperative delirium: a systematic review and meta-analysis
.
J Am Geriatr Soc
2014
;
62
:
2383
90
.

7

Lowery
DP
,
Wesnes
K
,
Ballard
CG
.
Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium
.
Dement Geriatr Cogn Disord
2007
;
23
:
390
4
.

8

Smith
PJ
,
Attix
DK
,
Weldon
BC
,
Greene
NH
,
Monk
TG
.
Executive function and depression as independent risk factors for postoperative delirium
.
Anesthesiology
2009
;
110
:
781
7
.

9

Greene
NH
,
Attix
DK
,
Weldon
BC
,
Smith
PJ
,
McDonagh
DL
,
Monk
TG
.
Measures of executive function and depression identify patients at risk for postoperative delirium
.
Anesthesiology
2009
;
110
:
788
95
.

10

Jankowski
CJ
,
Trenerry
MR
,
Cook
DJ
et al. .
Cognitive and functional predictors and sequelae of postoperative delirium in elderly patients undergoing elective joint arthroplasty
.
Anesth Analg
2011
;
112
:
1186
93
.

11

Fong
TG
,
Hshieh
TT
,
Wong
B
et al. .
Neuropsychological profiles of an elderly cohort undergoing elective surgery and the relationship between cognitive performance and delirium
.
J Am Geriatr Soc
2015
;
63
:
977
82
.

12

van Munster
BC
,
Korevaar
JC
,
Zwinderman
AH
,
Leeflang
MM
,
de Rooij
SE
.
The association between delirium and the apolipoprotein E epsilon 4 allele: new study results and a meta-analysis
.
Am J Geriatr Psychiatry
2009
;
17
:
856
62
.

13

Bryson
GL
,
Wyand
A
,
Wozny
D
,
Rees
L
,
Taljaard
M
,
Nathan
H
.
A prospective cohort study evaluating associations among delirium, postoperative cognitive dysfunction, and apolipoprotein E genotype following open aortic repair
.
Can J Anaesth
2011
;
58
:
246
55
.

14

Alexander
SA
,
Ren
D
,
Gunn
SR
et al. .
Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients
.
Am J Crit Care
2014
;
23
:
49
57
.

15

Oldenbeuving
AW
,
de Kort
PLM
,
Kappelle
LJ
,
van Duijn
CM
,
Roks
G
.
Delirium in the Acute Phase After Stroke and the Role of the Apolipoprotein E Gene
.
Am J Geriatr Psychiatry
2013
;
21
:
935
7
.

16

Charlson
ME
,
Pompei
P
,
Ales
KL
,
MacKenzie
CR
.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
.
J Chronic Dis
1987
;
40
:
373
83
.

17

ASA Physical Status Classification System [Internet]. Available from https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system (20 March 2017, date last accessed)

18

Rudolph
JL
,
Jones
RN
,
Grande
LJ
et al. .
Impaired executive function is associated with delirium after coronary artery bypass graft surgery
.
J Am Geriatr Soc
2006
;
54
:
937
41
.

19

Oveisgharan
S
,
Hachinski
V
.
Hypertension, executive dysfunction, and progression to dementia: the canadian study of health and aging
.
Arch Neurol
2010
;
67
:
187
92
.

20

Folstein
MF
,
Folstein
SE
,
McHugh
PR
.
‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician
.
J Psychiatr Res
1975
;
12
:
189
98
.

21

Inouye
SK
,
van Dyck
CH
,
Alessi
CA
,
Balkin
S
,
Siegal
AP
,
Horwitz
RI
.
Clarifying confusion: the co\nfusion assessment method. A new method for detection of delirium
.
Ann Intern Med
1990
;
113
:
941
8
.

22

American Psychiatric Association
.
Diagnostic and Statistical Manual of Mental Disorders
.
Washington, DC
:
American Psychiatric Association
,
2000
. Report No.: 4th edition.

23

Chester
JG
,
Beth Harrington
M
,
Rudolph
JL
,
VA Delirium Working Group
.
Serial administration of a modified Richmond agitation and sedation scale for delirium screening
.
J Hosp Med
2012
;
7
:
450
3
.

24

Belbin
O
,
Dunn
JL
,
Ling
Y
et al. .
Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease
.
Hum Mol Genet
2007
;
16
:
2199
208
.

25

McKay
GJ
,
Silvestri
G
,
Chakravarthy
U
et al. .
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people
.
Am J Epidemiol
2011
;
173
:
1357
64
.

26

Leung
JM
,
Sands
LP
,
Wang
Y
et al. .
Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery
.
Anesthesiology
2007
;
107
:
406
11
.

27

von Elm
E
,
Altman
DG
,
Egger
M
et al. .
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
.
J Clin Epidemiol
2008
;
61
:
344
9
.

28

Abelha
FJ
,
Fernandes
V
,
Botelho
M
et al. .
Apolipoprotein E e4 allele does not increase the risk of early postoperative delirium after major surgery
.
J Anesth
2012
;
26
:
412
21
.

29

Vasunilashorn
SM
,
Ngo
L
,
Kosar
CM
et al. .
Does Apolipoprotein E Genotype Increase Risk of Postoperative Delirium
.
Am J Geriatr Psychiatry
2015
;
23
:
1029
37
.

30

D'Elia
LF
,
Satz
PJ
,
Uchiyama
CL
,
White
T
Color trails test. Professional manual.
Odessa, FL
:
Psychological Assessment Resources
,
1996
.

31

Kenny
RA
,
Coen
RF
,
Frewen
J
,
Donoghue
OA
,
Cronin
H
,
Savva
GM
.
Normative values of cognitive and physical function in older adults: findings from the Irish Longitudinal Study on Ageing
.
J Am Geriatr Soc
2013
;
61
:
S279
90
.

32

Vaurio
LE
,
Sands
LP
,
Wang
Y
,
Mullen
EA
,
Leung
JM
.
Postoperative delirium: the importance of pain and pain management
.
Anesth Analg
2006
;
102
:
1267
73
.

33

Leung
JM
,
Sands
LP
,
Lim
E
,
Tsai
TL
,
Kinjo
S
.
Does preoperative risk for delirium moderate the effects of postoperative pain and opiate use on postoperative delirium
.
Am J Geriatr Psychiatry
2013
;
21
:
946
56
.

34

Kosar
CM
,
Tabloski
PA
,
Travison
TG
et al. .
Effect of preoperative pain and depressive symptoms on the development of postoperative delirium
.
Lancet Psychiatry
2014
;
1
:
431
6
.

35

Scott
JE
,
Mathias
JL
,
Kneebone
AC
.
Incidence of delirium following total joint replacement in older adults: a meta-analysis
.
Gen Hosp Psychiatry
2015
;
37
:
223
9
.

36

Marcantonio
ER
,
Ngo
LH
,
O'Connor
M
et al. .
3D-CAM: derivation and validation of a 3-minute diagnostic interview for CAM-defined delirium: a cross-sectional diagnostic test study
.
Ann Intern Med
2014
;
161
:
554
61
.

37

Evered
LA
,
Silbert
BS
,
Scott
DA
,
Maruff
P
,
Ames
D
,
Choong
PF
.
Preexisting cognitive impairment and mild cognitive impairment in subjects presenting for total hip joint replacement
.
Anesthesiology
2011
;
114
:
1297
304
.

Supplementary data

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.